New mRNA vaccine for pancreatic cancer shows promising early results.

Personalized mRNA vaccines for pancreatic cancer have shown safe and feasible outcomes in a small trial, delivering instructions to certain cells to produce a protein that triggers an immune response and attacks cancer cells in the pancreas. However, experts say it could be many years before the vaccines are available to patients, as larger clinical trials are needed to prove efficacy and safety. Pancreatic cancer is one of the deadliest forms of cancer, killing about 88% of people who are diagnosed with it, and is one of the most challenging types of cancer to treat.